Tuesday 13 December 2011
Subscribe to:
Post Comments (Atom)
skip to main |
skip to sidebar
NEWS AND VIEWS FROM THE PHARMACEUTICAL FINE CHEMICAL AND CUSTOM MANUFACTURING SECTOR
Fine
The FINE blog keeps you up-to-date on the pharmaceutical fine chemical and custom manufacturing sector. The weekly FINE Newsletter gives senior pharmaceutical fine chemical and custom manufacturing leaders a weekly summary of the key news stories and trends for the sector. The FINE Newsletter and blog focus on coverage of companies in the pharmaceutical fine chemical custom manufacturing sector, without forgetting key news from their customers in the pharma industry.
Subscribe
To receive the newsletter, each week, please subscribe.
Advertising
|
|
|
|
||
| Read this FREE online! Full Book | PDF Summary | Podcast | ||
Blog Archive
-
▼
2011
(306)
-
▼
December
(18)
- AMRI restructures for 2012
- Angel Biotechnology has raised £1.15m through a pl...
- Lonza has introduced a new plasmid DNA production ...
- Cambrex's manufacturing site in Charles City, Iowa...
- Angel Biotechnology has signed a Framework Agreeme...
- GE and M+W to build biopharma manufacturing plants
- Lonza expands early phase manufacturing in China
- DSM Pharmaceutical Products will manufacture and s...
- EMA and FDA to collaborate on GMP inspections
- Australian biologics facility moves closer
- Lonza is one of a number of companies receiving a ...
- IMCD has acquired Organotec
- Novasep restructures balance sheet
- A UK court has found for Albemarle in a case again...
- Shasun aims for growth
- Boehringer Ingelheim will manufacture Aveo Pharmac...
- Vivimed acquires Uquifa
- Lonza will manufacture the API for Elan's ELND005
-
▼
December
(18)
Technorati
Copyright ©2007, 2008 FINE. All rights reserved.
No comments:
Post a Comment